Potent and selective class IIa HDAC tetrasubstituted cyclopropane hydroxamic acid inhibitors were identified with high oral bioavailability that exhibited good brain and muscle exposure. Compound 14 displayed suitable properties for assessment of the impact of class IIa HDAC catalytic site inhibition in preclinical disease models.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716601 | PMC |
| http://dx.doi.org/10.1021/acsmedchemlett.5b00302 | DOI Listing |
Publication Analysis
Top Keywords
class iia
12
potent selective
8
tetrasubstituted cyclopropane
8
iia hdac
8
selective cns-penetrant
4
cns-penetrant tetrasubstituted
4
cyclopropane class
4
iia histone
4
histone deacetylase
4
deacetylase hdac
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!